This session brings together leading international experts to discuss the latest evidence from major clinical trials evaluating the role of indocyanine green (ICG) fluorescence imaging in reducing anastomotic leak rates in colorectal and rectal cancer surgery. From qualitative perfusion assessment to emerging quantitative analysis, the speakers will present pivotal results from their landmark studies that are shaping best practices and guiding the future adoption of fluorescence-guided surgery.